The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
Open accessAbstract
Although polyenes were the first broad spectrum antifungal drugs on the market, after 70 years they are still the gold standard to treat a variety of fungal infections. Polyenes such as amphotericin B have a controversial image. They are the antifungal drug class with the broadest spectrum, resistance development is still relatively rare and fungicidal properties are extensive. Yet, they come with a significant host toxicity that limits their use. Relatively recently, the mode of action of polyenes has been revised, new mechanisms of drug resistance were discovered and emergent polyene resistant species such as Candida auris entered the picture. This review provides a short description of the history and clinical use of polyenes, and focusses on the ongoing debate concerning their mode of action, the diversity of resistance mechanisms discovered to date and the most recent trends in polyene resistance development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Self-citationLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 4×
“Another mechanism of stress tolerance and/or resistance upon AmB exposure is likely governed by the molecular chaperone heat shock protein 90 (Hsp90), a highly connected, central factor in cellular stress responses that possibly potentiates the acquisition of resistance by regulating a myriad of client proteins [71,72…”
BackgroundInfluentialThe damage-response framework of microbial pathogenesis
Casadevall, A., & Pirofski, L.-A. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro732 · Cited by 658
Amphotericin primarily kills yeast by simply binding ergosterol
Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., & Burke, M. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117280109 · Cited by 608 · cited 2×
“Polyenes could adsorb ergosterol molecules to the “surface” of the phospholipid bilayer as illustrated in Figure 3C, termed the ”surface adsorption model” [33,49].”
BackgroundChowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs · doi:10.1007/s40265-016-0538-7 · Cited by 537
Amphotericin forms an extramembranous and fungicidal sterol sponge
Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., Wang, S., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1496 · Cited by 528
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498
Amphotericin B: spectrum and resistance
Ellis, D. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.suppl_1.7 · Cited by 473
Antifungal resistance: current trends and future strategies to combat
Wiederhold, N. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s124918 · Cited by 468
Chow, N. A., Muñoz, J. F., Gade, L., Berkow, E., Li, X., Welsh, R. M., Forsberg, K., Lockhart, S. R., Adam, R., Alanio, A., et al. (2020) · doi:10.1101/2020.01.06.896548 · Cited by 463
Muñoz, J. F., Gade, L., Chow, N. A., Loparev, V. N., Juieng, P., Berkow, E. L., Farrer, R. A., Litvintseva, A. P., & Cuomo, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07779-6 · Cited by 458 · cited 2×
“[84] showed an upregulation of ERG13, ERG6, ERG2 and ERG1 upon AmB exposure in AmB resistant C.”
BackgroundHusain, S., Munoz, P., Forrest, G., Alexander, B. D., Somani, J., Brennan, K., Wagener, M. M., & Singh, N. (2005) · Clinical Infectious Diseases · doi:10.1086/426445 · Cited by 401
Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398 · cited 4×
“A well-known example of this occurs upon inactivation of the target of azoles ERG11 and ERG3, resulting in the abrogation of the biosynthesis of ergosterol and inhibition of the synthesis of the toxic sterol 14-methyl-3,6-diol, respectively [58].”
BackgroundInfluentialPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Bijie, H., Dzierzanowska, D., Klimko, N. N., Letscher-Bru, V., Lisalova, M., Muehlethaler, K., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01747-08 · Cited by 370
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeffler, J., Hebart, H., Schumacher, U., & Einsele, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01360-9 · Cited by 351 · cited 1×
“Given the severe fitness deficits of mutations in the ergosterol biosynthesis pathway [20], AmB resistance is rarely found in combination with resistance to other antifungal drugs, although certain polyene resistance inducing ERG mutations can result in cross resistance to azoles [58,65,66].”
BackgroundBern, C., Adler‐Moore, J., Berenguer, J., Boelaert, M., Boer, M. D., Davidson, R. N., Figueras, C., Gradoni, L., Kafetzis, D. A., Ritmeijer, K., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/507530 · Cited by 345
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 1×
“The connection between Hsp90 and antifungal resistance can be investigated through the use of Hsp90 inhibitors such as geldanamycin and radicicol [73,74].”
BackgroundFitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322 · cited 8×
“Given the severe fitness deficits of mutations in the ergosterol biosynthesis pathway [20], AmB resistance is rarely found in”
BackgroundResultInfluentialLiu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., & Rogers, P. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2226-2236.2005 · Cited by 313
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Mesa-Arango, A. C., Scorzoni, L., & Zaragoza, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00286 · Cited by 311 · cited 3×
“As AmB evokes oxidative damage to DNA that leads to apoptosis [53], DNA damage checkpoint proteins might be involved in AmB resistance, although this link has not been confirmed.”
BackgroundInfluentialRex, J. H., Pfaller, M. A., Barry, A. L., Nelson, P. W., & Webb, C. D. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.40 · Cited by 301
Lockhart, S. R., Iqbal, N., Cleveland, A. A., Farley, M. M., Harrison, L. H., Bolden, C. B., Baughman, W., Stein, B., Hollick, R., Park, B. J., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01283-12 · Cited by 299
Infections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases
Steinbach, W. J., Benjamin, D. K., Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H., & Walsh, T. J. (2004) · Clinical Infectious Diseases · doi:10.1086/421950 · Cited by 293
Amphotericin B-Induced Oxidative Damage and Killing of Candida albicans
Sokol-Anderson, M. L., Brajtburg, J., & Medoff, G. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/154.1.76 · Cited by 287
Almyroudis, N. G., Sutton, D. A., Fothergill, A. W., Rinaldi, M. G., & Kusne, S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00452-07 · Cited by 285
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Meis, J. F., Gould, I. M., Fu, W., Colombo, A. L., & Rodriguez-Noriega, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00409-07 · Cited by 284
The Multifunctional Fungal Ergosterol
Rodrigues, M. L. (2018) · mBio · doi:10.1128/mbio.01755-18 · Cited by 275
Chemistry and biology of the polyene macrolide antibiotics.
Hamilton-Miller, J. M. T. (1973) · Bacteriological Reviews · doi:10.1128/mmbr.37.2.166-196.1973 · Cited by 274
Welscher, Y. M. T., Napel, H. H. T., Balagué, M. M., Souza, C. M., Riezman, H., de Kruijff, B., & Breukink, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707821200 · Cited by 274
Aspergillus Section Fumigati : Antifungal Susceptibility Patterns and Sequence-Based Identification
Alcazar-Fuoli, L., Mellado, E., Alastruey-Izquierdo, A., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00942-07 · Cited by 258
Yeast Rad17/Mec3/Ddc1: A sliding clamp for the DNA damage checkpoint
Majka, J., & Burgers, P. M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437148100 · Cited by 255
Polyene Macrolide Antibiotics and their Applications in Human Therapy
Zotchev, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368448 · Cited by 251
Espinel-Ingroff, A., Aller, A. I., Canton, E., Castañón-Olivares, L. R., Chowdhary, A., Cordoba, S., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Govender, N., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01115-12 · Cited by 251
Cendejas-Bueno, E., Kolecka, A., Alastruey-Izquierdo, A., Theelen, B., Groenewald, M., Kostrzewa, M., Cuenca-Estrella, M., Gómez-López, A., & Boekhout, T. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02248-12 · Cited by 237
Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Chaabane, F., Graf, A., Jequier, L., & Coste, A. T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02788 · Cited by 223
Escandón, P., Chow, N. A., Caceres, D. H., Gade, L., Berkow, E. L., Armstrong, P., Rivera, S., Misas, E., Duarte, C., Moulton-Meissner, H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy411 · Cited by 222
Nguyen, M. H., Clancy, C. J., Yu, V. L., Yu, Y. C., Morris, A. J., Snydman, D. R., Sutton, D. A., & Rinaldi, M. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/514193 · Cited by 219
Cuenca-Estrella, M., Ruiz-Díez, B., Martínez-Suárez, J. V., Monzón, A., & Rodríguez-Tudela, J. L. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.149 · Cited by 212
Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211 · cited 3×
“Additionally, a mutation was found in a gene predicted to encode the DNA damage checkpoint protein Mec3 [86], part of the Rad17p-Mec3p-Ddc1p sliding clamp [87].”
BackgroundSelf-citationCandida auris and multidrug resistance: Defining the new normal
Lockhart, S. R. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103243 · Cited by 205
Geber, A., Hitchcock, C. A., Swartz, J. E., Pullen, F. S., Marsden, K. E., Kwon-Chung, K. J., & Bennett, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2708 · Cited by 203
Li, R.-K., Ciblak, M. A., Nordoff, N., Pasarell, L., Warnock, D. W., & McGinnis, M. R. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1734-1736.2000 · Cited by 199
Howden, B. P., Slavin, M. A., Schwarer, A. P., & Mijch, A. M. (2003) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0877-z · Cited by 198
Multiple Functions of Sterols in Yeast Endocytosis
Heese-Peck, A., Pichler, H., Zanolari, B., Watanabe, R., Daum, G., & Riezman, H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-04-0186 · Cited by 190
Baddley, J. W., Marr, K. A., Andes, D. R., Walsh, T. J., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Balajee, S. A., Pappas, P. G., & Moser, S. A. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00854-09 · Cited by 190
Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae
Young, L. Y., Hull, C. M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2717-2724.2003 · Cited by 186
Kamiński, D. M. (2014) · European Biophysics Journal · doi:10.1007/s00249-014-0983-8 · Cited by 181
Susceptibility Patterns and Molecular Identification of Trichosporon Species
Rodriguez-Tudela, J. L., Diaz-Guerra, T. M., Mellado, E., Cano, V., Tapia, C., Perkins, A., Gomez-Lopez, A., Rodero, L., & Cuenca-Estrella, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4026-4034.2005 · Cited by 179
Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris
Kean, R., & Ramage, G. (2019) · mSphere · doi:10.1128/msphere.00458-19 · Cited by 177
Messer, S. A., Jones, R. N., & Fritsche, T. R. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1782-1787.2006 · Cited by 172
Aspergillus species intrinsically resistant to antifungal agents
Van Der Linden, J. W. M., Warris, A., & Verweij, P. E. (2011) · Medical Mycology · doi:10.3109/13693786.2010.499916 · Cited by 169
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165 · cited 1×
“albicans is associated with a substitution in ERG11 and loss of function of ERG5 (C-22 sterol desaturase), again associated with an alternate membrane sterol composition [20,59].”
BackgroundPfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J., & Jones, R. N. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.78-83.2003 · Cited by 165
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options
Riley, T. T., Muzny, C. A., Swiatlo, E., & Legendre, D. P. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016655425 · Cited by 165
Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006
Lamaris, G. A., Chamilos, G., Lewis, R. E., Safdar, A., Raad, I. I., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/509579 · Cited by 163
Chagas-Neto, T. C., Chaves, G. M., Melo, A. S. A., & Colombo, A. L. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01614-08 · Cited by 161
Potential Basis for Amphotericin B Resistance in Aspergillus terreus
Blum, G., Perkhofer, S., Haas, H., Schrettl, M., Würzner, R., Dierich, M. P., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01280-07 · Cited by 161
Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales
Vitale, R. G., de Hoog, S., Schwarz, P., Dannaoui, É., Deng, S., Machouart, M., Voigt, K., van de Sande, W. W. J., Dolatabadi, S., Meis, J. F. G. M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06133-11 · Cited by 155
Arıkan, S., Lozano‐Chiu, M., Paetznick, V. L., Nangia, S., & Rex, J. H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.3946-3951.1999 · Cited by 155
Ergosterol promotes pheromone signaling and plasma membrane fusion in mating yeast
Jin, H., McCaffery, J. M., & Grote, E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200705076 · Cited by 145
Protection of Fungi against Polyene Antibiotics by Sterols
GOTTLIEB, D., Carter, H. E., Sloneker, J. H., & Ammann, A. (1958) · Science · doi:10.1126/science.128.3320.361 · Cited by 144
Palanisamy, M., Abdel-Hadi, A., Singh, Y. R. B., Rajaraman, R., Raghavan, A., Banawas, S., Dukhyil, A. A. B., Alshehri, B., Shobana, C. S., Selvam, K. P., et al. (2019) · BioMed Research International · doi:10.1155/2019/6395840 · Cited by 139
Palacios, D. S., Anderson, T. M., & Burke, M. D. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075739o · Cited by 135
Kelly, S. L., Lamb, D. C., Taylor, M., Corran, A. J., Baldwin, B. C., & Powderly, W. G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07140.x · Cited by 133
Sangalli-Leite, F., Scorzoni, L., Mesa-Arango, A. C., Casas, C., Herrero, E., Mendes‐Giannini, M. J. S., Rodríguez-Tudela, J. L., Cuenca‐Estrella, M., & Zaragoza, Ó. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.01.015 · Cited by 132
Brandt, M. E., Pfaller, M. A., Hajjeh, R. A., Hamill, R. J., Pappas, P. G., Reingold, A. L., Rimland, D., & Warnock, D. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3065-3069.2001 · Cited by 125
The Discovery and Development of Amphotericin B
Dutcher, J. D. (1968) · Diseases of the Chest · doi:10.1378/chest.54.supplement_1.296 · Cited by 122
Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols
Readio, J. D., & Bittman, R. (1982) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(82)90103-1 · Cited by 121
Wang, H., Xiao, M., Chen, S. C.-A., Kong, F., Sun, Z., Liao, K., Lü, J., Shao, H., Yan, Y., Fan, H. S., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01130-12 · Cited by 116
Polyene antibiotic that inhibits membrane transport proteins
Welscher, Y. M. T., van Leeuwen, M. R., KRUIJFF, B. D., Dijksterhuis, J., & Breukink, E. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203375109 · Cited by 115
Park, B. J., Arthington-Skaggs, B. A., Hajjeh, R. A., Iqbal, N., Ciblak, M. A., Lee-Yang, W., Hairston, M. D., Phelan, M., Plikaytis, B. D., Sofair, A. N., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1287-1292.2006 · Cited by 113 · cited 1×
“[168] showed that the commonly used breakpoint of 2 μg/mL for Candida spp.”
MethodSokol-Anderson, M., Sligh, J. E., Elberg, S., Brajtburg, J., Kobayashi, G. S., & Medoff, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.702 · Cited by 113 · cited 1×
“Several observations point towards oxidative damage as an additional mode of action of AmB [51,52].”
BackgroundCohen, B. E. (2010) · The Journal of Membrane Biology · doi:10.1007/s00232-010-9313-y · Cited by 113
The pore-forming action of polyenes: From model membranes to living organisms
Kristanc, L., Božič, B., Jokhadar, Š. Z., Dolenc, M. S., & Gomišček, G. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.11.006 · Cited by 110
Guo, L., Yu, S.-Y., Hsueh, P., Al‐Hatmi, A. M. S., Meis, J. F. G. M., Hagen, F., Xiao, M., Wang, H., Barresi, C., Zhou, M., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01505-18 · Cited by 110
Steinbach, W. J., Schell, W. A., Miller, J. L., & Perfect, J. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3981-3985.2003 · Cited by 105
Emerging moulds: epidemiological trends and antifungal resistance
Miceli, M. H., & Lee, S. A. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02032.x · Cited by 104
Natamycin Inhibits Vacuole Fusion at the Priming Phase via a Specific Interaction with Ergosterol
Welscher, Y. M. T., Jones, L., van Leeuwen, M. R., Dijksterhuis, J., KRUIJFF, B. D., Eitzen, G., & Breukink, E. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01794-09 · Cited by 104
Chemistry and biology of the polyene macrolide antibiotics
Hamilton-Miller, J. M. T. (1973) · Bacteriological Reviews · doi:10.1128/br.37.2.166-196.1973 · Cited by 103
Management of invasive fungal infections: a role for polyenes
Chandrasekar, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq479 · Cited by 100
Candida lusitaniaeInfections in the Era of Fluconazole Availability
Hawkins, J. L., & Baddour, L. M. (2003) · Clinical Infectious Diseases · doi:10.1086/344651 · Cited by 98
Antifungal Susceptibility Testing of Fusarium: A Practical Approach
Al‐Hatmi, A. M. S., Curfs-Breuker, I., de Hoog, S., Meis, J. F. G. M., & Verweij, P. E. (2017) · Journal of Fungi · doi:10.3390/jof3020019 · Cited by 98
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
Minari, A., Hachem, R., & Raad, I. (2001) · Clinical Infectious Diseases · doi:10.1086/318473 · Cited by 96
Ahmad, S., Joseph, L., Parker, J. E., Asadzadeh, M., Kelly, S. L., Meis, J. F. G. M., & Khan, Z. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01900-18 · Cited by 95
On the role of sterol in the formation of the amphotericin B channel
Cotero, B. V., Rebolledo-Antúnez, S., & Ortega‐Blake, I. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00134-5 · Cited by 91
Clancy, C. J., & Nguyen, M. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1289 · Cited by 89
Alteration of Cell Wall Composition Leads to Amphotericin B Resistance in Aspergillus flavus
Seo, K., Akiyoshi, H., & Ohnishi, Y. (1999) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1999.tb01231.x · Cited by 88
Cross-resistance to polyene and azole drugs in Cryptococcus neoformans
Joseph‐Horne, T., Hollomon, D. W., Loeffler, R. S. T., & Kelly, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1526 · Cited by 88
Mesa-Arango, A. C., Rueda, C., Román, E., Quintin, J., Terrón, M. C., Luque, D., Netea, M. G., Pla, J., & Zaragoza, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02681-15 · Cited by 86
Design of amphotericin B oral formulation for antifungal therapy
Liu, M., Chen, M., & Yang, Z. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1225852 · Cited by 85
In vitro activity of antifungals against Zygomycetes
Alastruey‐Izquierdo, A., Castelli, M. V., Cuesta, I., Zaragoza, Ó., Monzón, A., Mellado, E., & Rodríguez-Tudela, J. L. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02984.x · Cited by 84
Francisco, E. C., de Almeida, J. N., Telles, F. D. Q., Aquino, V. R., Mendes, A. V. A., Barberino, M. G., Castro, P. D. T. O. E., Guimarães, T., Hahn, R. C., Padovan, A. C. B., et al. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.026 · Cited by 81
Mouri, R., Konoki, K., Matsumori, N., Oishi, T., & Murata, M. (2008) · Biochemistry · doi:10.1021/bi800334p · Cited by 80
Taj‐Aldeen, S. J., Al-Ansari, N., Shafei, S. E., Meis, J. F. G. M., Curfs-Breuker, I., Theelen, B., & Boekhout, T. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02222-08 · Cited by 78
Drogari‐Apiranthitou, M., Mantopoulou, F.-D., Skiada, A., Kanioura, L., Grammatikou, M., Vrioni, G., Mitroussia-Ziouva, A., Tsakris, A., & Petrikkos, G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks137 · Cited by 76
Lamp-Freund, M. T., Ferreira, V. F. N., & Schreier, S. (1985) · Journal of antibiotics (Tokyo. 1968) · doi:10.7164/antibiotics.38.753 · Cited by 76
Aspergillus terreus: Novel lessons learned on amphotericin B resistance
Posch, W., Blatzer, M., Wilflingseder, D., & Lass‐Flörl, C. (2018) · Medical Mycology · doi:10.1093/mmy/myx119 · Cited by 74
Cuddihy, G., Wasan, E. K., Di, Y., & Wasan, K. M. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030099 · Cited by 73
Borman, A. M., Muller, J., Walsh-Quantick, J., Székely, A., Patterson, Z., Palmer, M. D., Fraser, M., & Johnson, E. M. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz568 · Cited by 73
Badiee, P., & Alborzi, A. (2011) · Europe PMC (PubMed Central) · Cited by 72
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69
In vitro susceptibility of Cryptococcus gattii clinical isolates
Gómez‐López, A., Zaragoza, Ó., Martins, M. D. A., Melhem, M. D. S. C., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02021.x · Cited by 69
Goldman, C., Akiyama, M. J., Torres, J., et al. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.04.005 · Cited by 69
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B
McGinnis, M. R., Nordoff, N. G., Li, R.-K., Pasarell, L., & Warnock, D. W. (2001) · Medical Mycology · doi:10.1080/mmy.39.4.369.371 · Cited by 68
Reichert‐Lima, F., Lyra, L., Pontes, L., Moretti, M. L., Pham, C. D., Lockhart, S. R., & Schreiber, A. Z. (2018) · Mycoses · doi:10.1111/myc.12759 · Cited by 68
Yang, Y.-L., Wang, A.-H., Wang, C., Cheng, W.-T., Li, S., & Lo, H. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.01.011 · Cited by 67
Scedosporium Species Infections and Treatments
Steinbach, W., & Perfect, J. (2003) · Journal of chemotherapy · doi:10.1179/joc.2003.15.supplement-2.16 · Cited by 64
Cordeiro, R. D. A., Evangelista, A. J. D. J., Serpa, R., Marques, F. J. D. F., Melo, C. V. S. D., Oliveira, J. S. D., Franco, J. D. S., Alencar, L. P. D., Bandeira, T. D. J. P. G., Brilhante, R. S. N., et al. (2016) · Microbiology · doi:10.1099/mic.0.000222 · Cited by 63
Shin, J. H., Kim, M., Jang, S. J., Ju, M. Y., Kim, S. H., Shin, M., Suh, S., & Ryang, D. W. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06440-11 · Cited by 63
Maraki, S., Mavromanolaki, V. E., Stafylaki, D., Nioti, E., Hamilos, G., & Kasimati, A. (2019) · Mycoses · doi:10.1111/myc.12946 · Cited by 60
Pan-resistant Candida auris: New York subcluster susceptible to antifungal combinations
O'Brien, B., Liang, J., Chaturvedi, S., Jacobs, J. L., & Chaturvedi, V. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30090-2 · Cited by 60
Perkins, A., Gómez‐López, A., Mellado, E., Rodrı́guez-Tudela, J. L., & Cuenca‐Estrella, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki393 · Cited by 58
Hou, X., Xiao, M., Chen, S. C.-A., Wang, H., Cheng, J., Chen, X., Xu, Z., Fan, X., Kong, F., & Xu, Y. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01492-16 · Cited by 58
Montoya, A. M., González, A. S., Palma‐Nicolás, J. P., Gómez‐Treviño, A., González‐González, J. G., & González, G. M. (2015) · Medical Mycology · doi:10.1093/mmy/myv009 · Cited by 56
Candida haemuloniiComplex Species, Brazil, January 2010–March 2015
de Almeida, J. N., Assy, J. G. P. L., Levin, A. S., Negro, G. M. B. D., Giudice, M. C., Tringoni, M. P., Thomaz, D. Y., Motta, A. L., Abdala, E., Pierrotti, L. C., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151610 · Cited by 55
Molecular bases of antifungal resistance in filamentous fungi
Sharma, C., & Chowdhary, A. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.06.018 · Cited by 55
Chandenier, J., Adoubryn, K. D., Douchet, C., Sar, B., Kombila, M., Swinne, D., Thérizol‐Ferly, M., Buisson, Y., & Richard-Lenoble, D. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1136-2 · Cited by 54
Blatzer, M., Blum, G., Jukic, E., Posch, W., Gruber, P., Nagl, M., Binder, U., Maurer, E., Sarg, B., Lindner, H. H., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05164-14 · Cited by 52
Lack of activity of amphotericin B in systemic murine fusarial infection.
Anaissie, E. J., Hachem, R. Y., Legrand, C., Legenne, P., Nelson, P. E., & Bodey, G. P. (1992) · PubMed · Cited by 51
Bourgeois, N., Dehandschoewercker, L., Bertout, S., Bousquet, P., Rispail, P., & Lachaud, L. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01096-09 · Cited by 51
Hagen, F., Hare, R. K., Meis, J. F. G. M., et al. (2016) · Mycoses · doi:10.1111/myc.12507 · Cited by 51
Amphotericin B resistant isolates ofCryptococcus neoformanswithout alteration in sterol biosynthesis
Joseph‐Horne, T., Loeffler, R. S. T., Hollomon, D. W., & Kelly, S. L. (1996) · Medical Mycology · doi:10.1080/02681219680000381 · Cited by 50
Ribeiro, M. A., Alastruey‐Izquierdo, A., Gómez‐López, A., Rodrı́guez-Tudela, J. L., & Cuenca‐Estrella, M. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70053-6 · Cited by 50
Unmasking the Amphotericin B Resistance Mechanisms in Candida haemulonii Species Complex
Silva, L. N., Oliveira, S. S. C., Magalhães, L. B., Andrade-Neto, V. V., Torres-Santos, E. C., de Carvalho, M. D. C., Pereira, M. D., Branquinha, M. H., & dos Santos, A. L. S. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00117 · Cited by 50
Matsuoka, S., Ikeuchi, H., Matsumori, N., et al. (2004) · Biochemistry · doi:10.1021/bi049001k · Cited by 49
Widespread amphotericin B-resistant strains of Aspergillus fumigatus in Hamilton, Canada
Ashu, E. E., Korfanty, G. A., Samarasinghe, H., Pum, N., You, M., Yamamura, D. L. R., & Xu, J. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s170952 · Cited by 49
Synthesis and Biophysical Studies on 35‐Deoxy Amphotericin B Methyl Ester
Szpilman, A. M., Cereghetti, D. M., Manthorpe, J. M., Wurtz, N. R., & Carreira, E. M. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200900231 · Cited by 48
Christenson, J. C., Guruswamy, A. P., Mukwaya, G., & RETTING, P. J. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198708000-00013 · Cited by 47
Arabatzis, M., Abel, P., Kanellopoulou, M., Adamou, D., Alexandrou-Athanassoulis, H., Stathi, A., Platsouka, E. D., Milioni, A., Pangalis, A., & Velegraki, A. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12501 · Cited by 45
Chemical studies with amphotericin B III. The complete structure of the antibiotic
Borowski, E., ZIELINSKI, J., Zimiński, T., Falkowski, L., Kołodziejczyk, P., Golik, J., JERECZEK, E., & Adlercreutz, H. (1970) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)98622-8 · Cited by 45
Lack of Activity of Amphotericin B in Systemic Murine Fusarial Infection
Anaissie, E. J., Hachem, R., Legrand, C., Legenne, P., Nelson, P., & Bodey, G. P. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/165.6.1155 · Cited by 42
Gómez‐López, A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.919 · Cited by 40
Candida lusitaniae in Kuwait: Prevalence, antifungal susceptibility and role in neonatal fungemia
Khan, Z., Ahmad, S., Al‐Sweih, N., Khan, S. I., & Joseph, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213532 · Cited by 39
Discovery of Amphamide, a Drug Candidate for the Second Generation of Polyene Antibiotics
Tevyashova, A. N., Бычкова, Е. Н., Solovieva, S. E., Zatonsky, G. V., Grammatikova, N. E., Борисовна, И. Е., Павловна, М. Е., Трещалин, И. Д., Переверзева, Э. Р., Bykov, E. E., et al. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00068 · Cited by 37
Lima, S. L., Francisco, E. C., de Almeida, J. N., Santos, D. W. D. C. L., Carlesse, F., Queiroz‐Telles, F., Melo, A. S. D. A., & Colombo, A. L. (2020) · Journal of Fungi · doi:10.3390/jof6030110 · Cited by 36
Koss, T., Bagheri, B., Zeana, C., et al. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120627 · Cited by 34
Yang, Y.-L., Li, S., Cheng, H.-H., & Lo, H. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-99 · Cited by 33
Amphotericin B Resistance in Aspergillus terreus Is Overpowered by Coapplication of Pro-oxidants
Blatzer, M., Jukic, E., Posch, W., Schöpf, B., Binder, U., Steger, M., Blum, G., Hackl, H., Gnaiger, E., Lass‐Flörl, C., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6220 · Cited by 33
Arechavala, A. I., Ochiuzzi, M. E., Borgnia, M. D., & Santiso, G. (2009) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.02.001 · Cited by 33
Effect of Amphotericin B on the Metabolic Profiles of Candida albicans
Cao, Y., Zhu, Z., Chen, X., Yao, X., Zhao, L., Wang, H., Yan, L., Wu, H.-T., Chai, Y., & Jiang, Y. (2013) · Journal of Proteome Research · doi:10.1021/pr4002178 · Cited by 31
Quantifying membrane permeability of amphotericin B ion channels in single living cells
Yang, T., Ou, K., Peng, P., Liou, B.-C., Wang, W., Huang, Y.-C., Tsai, C., & Su, C. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.03.021 · Cited by 29
Foglia, F., Lawrence, M. J., Demé, B., Fragneto, G., & Barlow, D. J. (2012) · Scientific Reports · doi:10.1038/srep00778 · Cited by 26
Kohler, L. M., Soares, B. M., Santos, D. A., Barros, M. E. D. S., & Hamdan, J. S. (2006) · Canadian Journal of Microbiology · doi:10.1139/w06-040 · Cited by 26
Woods, K., & Höfken, T. (2015) · Molecular Microbiology · doi:10.1111/mmi.13244 · Cited by 23
Is there a role for polyenes in treating invasive mycoses?
Cornely, O. A., Vehreschild, J. J., & Ullmann, A. J. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328010851d · Cited by 23
Rambach, G., Oberhauser, H., Speth, C., & Lass‐Flörl, C. (2011) · Medical Mycology · doi:10.3109/13693786.2011.583943 · Cited by 23
Iatta, R., Caggiano, G., Cuna, T., & Montagna, T. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.92 · Cited by 22
O'Keeffe, J., & Kavanagh, K. A. (2004) · PubMed · Cited by 7
A 9-Year Experience of Aspergillus Infections from Isfahan, Iran
Chadeganipour, M., & Mohammadi, R. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s259162 · Cited by 7
Experimental Animal Models of Invasive Fungal Infections
Imamura, Y. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-4 · Cited by 5
Cited by
Carolus, H., Pierson, S., Muñoz, J. F., Subotić, A., Cruz, R. B., Cuomo, C. A., & Van Dijck, P. (2021) · mBio · doi:10.1128/mbio.03333-20 · Cited by 211
Self-citationRogers, T. R., Verweij, P. E., Castanheira, M., Dannaoui, E., White, P. L., Arendrup, M. C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), Arendrup, M. C., Arikan-Akdagli, S., Barchiesi, F., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac161 · Cited by 82
Self-citationCarolus, H., Sofras, D., Boccarella, G., Sephton-Clark, P., Biriukov, V., Cauldron, N. C., Lobo Romero, C., Vergauwen, R., Yazdani, S., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01854-z · Cited by 72
Self-citationFungal biofilms in human health and disease
Ramage, G., Kean, R., Rautemaa-Richardson, R., Williams, C., & Lopez-Ribot, J. L. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01147-0 · Cited by 72
New antifungal strategies: Drug combination and co-delivery
Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63
Metadata
- Authors
- Carolus, H., Pierson, S., Lagrou, K., & Van Dijck, P.
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2020-11-27
- Volume
- 6
- Issue
- 4
- Pages
- 321
- ISSN
- 2309-608X (ISSN-L)
- OpenAlex
- W3107025072
- Cited by
- 349
- References
- 158
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.